Abstract Vascular anomalies of the head and neck region are a complex group of lesions that challenge the head and neck physicians. From the very understanding of the difference between its two distinct forms, hemangiomas and vascular malformations to its management remain confusing. The review of this anomaly attempts at comprehensively understanding the disease. Vascular anomalies are easily diagnosed by their clinical presentation, but choice of imaging and management for this spectrum of lesions is varied. The author attempts to categorize the required imaging for the lesion with suggestions on the management of both hemangiomas and vascular malformations. The available treatment options are discussed, and a comprehensive algorithm for management is suggested. Further research in developing drugs that could restrict the growth of these lesions would be the future of the management of vascular lesions.
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Vascular anomalies (VA) by the very terminology describe a broad spectrum of pathologies involving the vascular structures of the human body. Since the biological differentiation in its classification provided by Mulliken and Glowacki, some clarity has crept into the understanding of the disease. The complexity in diagnosing and therefore managing the pathology has been largely due to its varied spectrum of presentation. Management for VA varies from medical to minimally interventional and finally radical modalities. This article reviews the history, pathogenesis, classifications and available interventional measures in the literature and our own philosophy of management of vascular anomalies.
Historical Review and Nomenclature
Wardrop, a surgeon from London, first recognized in 1818 that vascular malformations were different from hemangioma [1] . This, however, did not help develop a philosophy of treatment. The first public demonstration of ether anesthesia by William Green Morton in 1846 was for surgical removal of a venous vascular malformation [2] .
For centuries, laymen and physicians called cutaneous vascular nevi by familiar words for food. The use of such terms as ''cherry'', ''port-wine stain'' and ''strawberry'' for vascular lesions can be traced back to this false doctrine of maternal impressions [3] . With the advent of histopathology in the middle of the nineteenth century, these anomalies became known as angiomas. Over the next 100 years, clinical and histological terms became hopelessly jumbled, impeding the development of this field.
Classifications
Rudolf Ludwig Karl Virchow (1863), the father of cellular pathology, deserves credit as the first to categorize vascular anomalies by microscopic channel architecture [4] . He called them angioma simplex, angioma cavernosum or angioma racemosum. Since then, many classifications have been proposed (Table 1) .
International Society for the Study of Vascular Anomalies (ISSVA) has proposed its first classification in 1988 in Hamburg, which is known as Hamburg classification. And it has been reviewed and modified several times since then, in 1992 in Colorado, in 1996 in Rome and most recently in 2014 in Melbourne [5] (Table 2) .
The author introduced a more practical classification to aid in the decision making with respect to diagnostic imaging and the surgical planning as follows [1] (Table 3) :
The malformations were categorized into five types depending on their anatomy and depth of location in the head and neck region. In type I superficial lesions requiring excision of skin or mucosa, local or regional flaps have been used in defect reconstruction. Type II submucosal lesions require complete excision after elevation of skin flaps. Type III lymphovenous malformations or venous malformations involving glands of the head and neck are excised along with the affected gland. Type IV intraosseous lesions require excision with involved bone and reconstruction when required. Type V lesions involving deep visceral spaces, such as the parapharyngeal or infratemporal fossa, require skeletal access osteotomy for complete exposure and total excision. The above classification helped in determining the surgical approach and reconstruction necessary for the type of vascular lesion.
Hemangiomas are subclassified into focal and segmental disease [6] . Focal hemangiomas are localized, unilocular lesions which adhere to the phases of growth and involution. Multifocal hemangiomatosis also exists, and infants with more than five lesions should undergo workup to rule out visceral involvement. Segmental hemangiomas are more diffuse plaque like and can lead to untoward functional and aesthetic outcomes. The limb and face are common locations for the disease.
Incidence
Overall, infantile hemangiomas have an incidence of 3-10% in the literature, but more evidenced study confirmed that it is likely 4-5% [7] . A multicentric prospective study with an aim to identify demographics of infantile hemangiomas concluded female gender, prematurity, multiple gestations, Caucasian ethnicity, low birth weight and advanced maternal age are the associated risk factors [8] .
Among vascular lesions, venous malformations are the common along with lymphatic ones having incidence of 1:5000-10,000, and surprisingly 40% of them usually occur in head and neck regions [9] .
Diagnosis
Clinical diagnosis of hemangiomas generally arises from making a thorough physical examination which considers the shape, consistency and character delineation and possible invasive lesion, with subsequent deterioration of vital functions. In most cases no further investigation is needed, but achieving the differential diagnosis of hemangiomas is imperative to rule out other diseases, which are potentially more serious.
Similarly, venous malformations occurring in superficial areas are usually easy to diagnose by clinical examination. However, for those lesions that are deep in the face and neck, it is sometimes difficult to make a correct diagnosis through clinical examination alone. Imaging studies using ultrasound (US), CT, MRI (MR hemography) are the best diagnostic scans [10] . There are clear differentiating features between hemangiomas ( Fig. 1 ) and vascular malformation ( Fig. 2 ) in their clinical presentation and behavior ( Table 4) .
The widespread introduction of modernized diagnostic imaging techniques like color Doppler ultrasound (CDUS), MRI, CECT scan, digital subtraction angiography (DSA) (catheterizing the entire vertebral or vascular tree) and MR venography for low-flow lesions has been aiding the surgeon to manage these lesions (Table 5) .
In few cases, it is not unusual to see the involvement of parenchyma that provides a valid reason to opt for additional imaging diagnostic modality such as MRI or CT (with or without contrast usage). Sometimes, Doppler USG may be useful in hemangiomas extending to other layers of skin, as a part of changes as in cysts or lymph node changes.
In T2 weighted images (Fig. 3) , venous malformations can appear as ''venous lakes''. MRI sectional images can avoid signal overlap and thereby demonstrate the relationship between the lesion and the deep structure. MRI is therefore superior to CT (Fig. 4 ) in demonstrating the relationship between the extent of the lesion and normal tissue.
Histopathologic Features [13] (Table 6) In distinction to hemangiomas, vascular malformations result from abnormal vascular or lymphatic morphogenesis, not due to abnormal endothelial proliferation. Despite some similarities in appearance between vascular malformations and hemangiomas, the histopathologic features are quite different.
Management of Vascular Anomalies
Several algorithms for management of vascular lesions have been proposed till date (Fig. 5 ). The following algorithm was proposed by R. Mattassi, D.A. Loos and M. Vaghi for congenital vascular anomalies (Fig. 6) .
These as well as other algorithms given proposed different approaches toward management of hemangioma and vascular malformations.
Management of Hemangiomas
Hemangiomas due to its biological behavior of proliferation followed by involution can be treated effectively with medications both systemic and intralesional.
As per the literature, around 90% infantile hemangiomas are small, focal and non-effective to function or aesthetics.
It is encouraged to have a close observation of these lesions during its proliferation [15] . Intervention is only necessary after involution phase, particularly in the presence of excess residual tissue, scarring or telangiectasia. Also, clear indications for intervention are also given when vital systems or structures such as airway or visual pathways are affected, risks of amblyopia, symptomatic or asymptomatic ulcerations, permanent disfigurement threatened by facial lesions or large lesions resulting in cardiac overload [16] .
Beta Blockers
The serendipity of Leaute-Labraze et al. in 2008 resulting in efficacious use of propranolol is remarkable [17] . In their original landmark study, they have done treatment for [29] No perilesional fibrosis [30] Possibility to perform multiple subsequent injections with additional shrinkage response
Low complication rate
Better aesthetics results [30] The main disadvantage of OK-432 is that some lesions require more than one injection to shrink satisfactorily. Other complications include fever, allergy, erythema and swelling [31] Detergent sclerosants (sodium tetradecyl, the most commonly used sclerosant, ethanolamine and polidocanol
Detergents came into use in the 1930s
They work by a mechanism known as protein theft denaturation Addition of air results in a microfoam which is felt to be more effective than the bland solution. A reasonable dose limit for image-guided Sclerotherapy is 0.5 ml/kg or 30.
It is painful to inject, but effective and relatively nontoxic hypertrophic obstructive cardiomyopathy in an infant with oral propranolol. Contrarily, Seigfried et al. warned for the side effects of propranolol which includes hypoglycemia, bradycardia, hypotension, bronchospasm, CHF, sleep disturbance and hypothermia and recommended the close monitoring of infants having propranolol therapy [18] . But in many case series reports, almost 100% efficacy has been reported in arresting these lesions, and vice versa, therapy failure has also been reported indicating use of alternate treatment modalities. Although many centers including the authors' have introduced this therapy as first line of treatment, trials are still going on to prove its efficacy and more conclusive data will be forthcoming [19] .
Steroids
Use of steroids in VM started in 1963 after an accidental find when a case of a thrombocytopenic child on systemic steroids (2-5 mg/kg/day) showed decrease in infantile hemangiomas [20] . In other large studies, when prednisolone was given in larger doses of 20 mg daily, it evidenced an 84% response after 2 months of initiating the therapy [21] . But 35% rate of side effects was also documented with this relatively high response rate. It is suggested that a mixture of triamcinolone 40 mg/ml and betamethasone 6 mg/ml in 1:1 ratio is to be injected 1-2 ml intralesionally, response of which may be rapid, much more favorable and drastic in a matter of few days. Local complications, one may expect, are periocular ophthalmic artery embolization, fat atrophy, cutaneous hypopigmentation, full-thickness eyelid necrosis and calcification, but these are avoidable with skill adaptations and following proper technique with recommended dosage.
Vincristine
It is an alkaloid cancer chemotherapeutic agent which induces apoptosis by interference with mitotic spindle microtubule. It can thus be used as an alternative to steroids for infantile hemangioma because of steroid-sparing effects. Although it has been documented with side effects like hematologic toxicity, peripheral neuropathy, jaw pain and constipation, its favorable efficacious results overcome these known risks or side effects [22] .
Interferon Alpha
It works as an anti-angiogenic agent with an advantage of steroid-saving effects. Although one case series documented regression of half or more lesions in 90% of cases treated by interferon alpha, this was associated with serious side effects of spastic diplegia and neutropenia [23] . Subsequently, this treatment modality was abandoned due to unacceptable high risk of neurotoxicity (10-30%) with its use, despite its favorable efficacious results [24] .
Management of VM
This is largely dependent on the fluid dynamics of the lesion. Preliminary imaging with US Doppler will differentiate a high flow from a low-flow lesion. In low-flow lesions with large vascular channels and spaces in the head and neck region, total excision is a surgical challenge and misadventure. The philosophy of management then hinges on decompressing the lesion or partial elimination. This [11] can be achieved with administration of intralesional medicaments which may be sclerosing in nature (Fig. 7) .
Intralesional sclerosants (Table 7) Sclerotherapy has become the current mainstream treatment for venous malformation. It can be used alone or combined with surgery and/or laser therapy. For large lesions, multiple treatments are necessary. Recurrence is seen; this may possibly happen with some sclerosing agents that incompletely treat the VMs being injected. The sclerosants commonly used are 5% sodium morrhuate, pingyangmycin (PYM), anhydrous ethanol and lauromacrogol. The mechanism of action of these sclerosing agents is clearly understood and unique in destroying the blood vessel's endothelial cells, acceleration of protein coagulation in blood of lesions, formation of thrombosis, platelets adhesion promotion and causing vascular occlusion through thrombotic mechanisms.
Laser Treatment
One of the non-medicinal modalities of treatment employed in IH is laser. Several types of laser have been tried, including argon laser, Nd:YAG laser, carbon dioxide laser, fractional photothermolysis and pulsed dye laser (PDL). Nd:YAG laser and KTP laser are most frequently used laser systems in the treatment of vascular malformations. Mechanism of action lies behind the ability of hemoglobin to absorb laser energy and generating a high temperature and that causes coagulation and immediate shrinkage of lesion. As these laser systems have the tendency to penetrate only 1-3 mm and to form a scar on nerves or skin of superficial lesion, their interstitial use has been recommended [32] .
Surgical Management
Surgery continues to be a viable alternative to all of the above modalities. Although it yields nearly instantaneous resolution of the lesion, it carries with it the risk of bleeding, despite the well-circumscribed nature of IH. Walker et al. demonstrated impressive clinical results following surgical removal of 12 visually significant hemangiomas, half of which had failed prior therapy; however, two of those cases also necessitated intraoperative blood transfusions due to hemorrhage [33] . Patients must be selected very carefully for excision accounting for the size, location and surgical risk to surrounding structures. Surgery is generally reserved for lesions that are refractory to less invasive treatments. Various techniques and technologies have aided in limiting and controlling intraoperative bleeding, rendering surgical excision a more favorable option in appropriate clinical scenarios.
The technique of intratumoral ligation was reported by Popescu in 1985 [34] . The aim of the treatment was to occlude by ligation the afferent and efferent vessels as well as the dilated vascular elements which make up the tumor mass. The technique required the use of large curved needles and strong suture material which would not cut out easily.
Corset Suturing
Similarly, the use of continuous vertical or horizontal mattress sutures helped compress the large venous compartments into smaller compartments which eventually replaces the vascular spaces with fibrous tissue. This technique was conveniently named Corset suturing by the author. The use of long-standing PDS sutures helped in the fibrous transformation and helped reduce size of the lesion (Figs. 8, 9 ).
Managing High-Flow Lesions
High-flow lesions such as AM or AVM's had the risk of excessive hemorrhage intraoperatively and needed presurgical vascular control prior to its excision. Vascular control in high-flow lesions could be achieved by ECA control or endovascular embolization (Table 8) .
The oldest form of surgical treatment for AVM's was proximal arterial ligation, which originated from Hunter's successful management of a popliteal aneurysm. This approach is rarely curative, however, and in fact runs a significant risk of compounding problems by putting a greater demand on collateral vessels. In this situation the collaterals not only sustain the original lesion but in the process of their subsequent enlargement act to increase its overall size. Judicious control rather than ligation was therefore the key.
Vascular Control (Understanding Embolization)
Embolization is defined as the ''therapeutic introduction of various substances into the circulation to occlude vessels, either to arrest or prevent hemorrhaging; to devitalize a structure, tumor, or organ by occluding its blood supply; or to reduce blood flow to an arteriovenous malformation'' [35] .
Embolization has three therapeutic goals in the treatment of vascular malformations which are adjunctive goal, curative goal and palliative goal. Specific materials used for embolization are ethanol, cyanoacrylate, coils, polyvinyl alcohol, sodium tetradecyl sulfate, gelatin sponge and microspheres (Fig. 10) .
Macrocoils and microcoils are of different sizes used for embolization. Platinum coils, type of microcoils, can be introduced into vascular system using microcatheters. These are highly radiopaque, thrombogenic and biocompatible. The potential disadvantages of this type of coil embolization are collateralization and proximal occlusion, making repeat embolization very difficult.
New interest has been inspired by the recent advances in terms of the course, its pathogenesis and successful treatment of infantile hemangiomas. One of the treatment modalities needs to be discussed here. As VEGF-A concentrations are high in infants with proliferative lesions, bevacizumab, an anti-VEGF antibody extracted from humans, has given remarkable results in early clinical trials in nosebleeds of patients suffering from hereditary hemorrhagic telangiectasia but currently clinical trials are still in process.
The management of vascular lesions starts from its very appearance and behavior. Identifying the type of lesion will determine its future management. There are several algorithms, as mentioned before, which help in the treatment protocol. The algorithm proposed by the author (Fig. 11) simplifies the decision making in the management of vascular anomalies.
In conclusion there are variables in managing individual vascular lesions and having a policy of ''One size fits all'' may be ill advised.
